azelnidipine has been researched along with Cardiac Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobashi, S; Fujii, T; Hisatake, S; Ikeda, T; Kabuki, T; Kiuchi, S; Oka, T | 2 |
| Cheng, XW; Harada, K; Hirashiki, A; Inoue, A; Jin, Z; Kuzuya, M; Murohara, T; Nagata, K; Obata, K; Okumura, K; Shi, GP; Takeshita, K; Unno, K; Yokota, M | 1 |
3 other study(ies) available for azelnidipine and Cardiac Failure
| Article | Year |
|---|---|
Azelnidipine is a useful medication for the treatment of heart failure preserved ejection fraction.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Echocardiography; Female; Heart Failure; Heart Rate; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Radionuclide Imaging; Renin-Angiotensin System; Stroke Volume | 2017 |
Effect of Switching from Cilnidipine to Azelnidipine on Cardiac Sympathetic Nerve Function in Patients with Heart Failure Preserved Ejection Fraction.
Topics: Adult; Aged; Aged, 80 and over; Azetidinecarboxylic Acid; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Drug Substitution; Echocardiography; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Male; Middle Aged; Radionuclide Imaging; Retrospective Studies; Stroke Volume; Sympathetic Nervous System; Treatment Outcome | 2018 |
Mechanism of diastolic stiffening of the failing myocardium and its prevention by angiotensin receptor and calcium channel blockers.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Azetidinecarboxylic Acid; Calcium Channel Blockers; Diastole; Dihydropyridines; Heart Failure; Imidazoles; Male; Myocardium; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Tetrazoles | 2009 |